当前位置: 首页 > 详情页

GBP3 promotes glioma cell proliferation via SQSTM1/p62-ERK1/2 axis

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [a]Department of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China [b]The Experimental Center, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China [c]Department of Neurology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China [d]Department of Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China [e]Department of Neurology, University of Virginia, Charlottesville, VA, USA
出处:
ISSN:

关键词: GBP3 Glioma Cell proliferation SQSTM1/p62 ERK1/2

摘要:
Guanylate binding proteins (GBPs) are interferon-inducible large GTPases and play a crucial role in cell autonomous immunity. However, the biology function of GBPs in cancer remains elusive. GBP3 is specifically expressed in adult brain. Here we show that GBP3 is highly elevated in human glioma tumors and glioma cell lines. Overexpression of GBP3 dramatically increased glioma cell proliferation whereas silencing GBP3 by RNA interference produced opposite effects. We further showed that GBP3 expression was able to induce sequestosome-1(SQSTM1, also named p62) expression and activate extracellular signal-regulated kinase (ERK1/2). The SQSTM1-ERK1/2 signaling cascade was essential for GBP3-promoted cell growth because depletion of SQSTM1 markedly reduced the phosphorylated ERK1/2 levels and GBP3-mediated cell growth, and inhibition of mitogen-activated protein kinase/ERK kinase abolished GBP3-induced glioma cell proliferation. Consistently, GBP3 overexpression significantly promoted glioma tumor growth in vivo and its expression was inversely correlated with the survival rate of glioma patients. Taken together, these results for the first time suggest that GBP3 contributes to the proliferation of glioma cells via regulating SQSTM1-ERK1/2 pathway, and GBP3 might represent as a new potential therapeutic target against glioma. (C) 2017 Elsevier Inc. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 3 区 生物
小类 | 4 区 生化与分子生物学 4 区 生物物理
最新[2023]版:
大类 | 3 区 生物学
小类 | 3 区 生物物理 4 区 生化与分子生物学
JCR分区:
出版当年[2016]版:
Q3 BIOPHYSICS Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY
最新[2023]版:
Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Q3 BIOPHYSICS

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [a]Department of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China [b]The Experimental Center, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China
通讯作者:
通讯机构: [*1]Department of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China [*2]Department of Neurology, University of Virginia, Charlottesville, VA, USA
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院